A significant development in recent days has seen a number of patients become reinfected with Covid 19. But what does the development mean in the race for a vaccine, can a vaccine defend against multiple potential strains of the virus? To discuss we were joined on the show by Paul Moynagh Professor of Immunology and Director of the Kathleen Lonsdale Institute for Human Health research at Maynooth University.
Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.
Download, listen and subscribe on the Newstalk App.
You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.
